Andrew Hoffman, DVM, DVSc, DACVIM is currently serving as Dean of the School of Veterinary Medicine at the University of Pennsylvania (since 2018). There he founded the first extracellular vesicle (EV) core in the USA at Penn, where he continues to serve and collaborate with the Penn community on projects related to the biogenesis, biomarker, and therapeutic potential of EV. His main research interest is the immunomodulatory potential of MSC derived EV.  Prior to his appointment at Penn, Dr. Hoffman was Director of the Regenerative Medicine Laboratory at Tufts Cummings School of Veterinary Medicine. In 2020-2021 he served on the ISCT Exosome Committee, ISEV Organizing Committee, and ISEV task force on CSF EV.